Neural Therapeutics Company Description

Neural Therapeutics Inc., an ethnobotanical drug discovery and development company, develops over-the-counter dietary supplements and psychedelic-based therapeutic drugs to treat mental illnesses in Canada.

The company utilizes psychoactive plants, such as San Pedro, a cactus containing mescaline, for the creation of plant-based traditional medicine.

Its products target substance use disorders, including alcohol and opioid dependence. The company was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in November 2021.

Neural Therapeutics Inc. was founded in 2020 and is headquartered in Toronto, Canada.

Neural Therapeutics Inc.

Country	Canada
Founded	2020
Industry	Biological Products, Except Diagnostic Substances
CEO	Ian Campbell

Contact Details

Address: 130 Adelaide Street West Toronto, Ontario M5H 3P5 Canada
Phone	647-697-6875
Website	neuraltherapeutics.ca

Stock Details

Ticker Symbol	NURL
Exchange	Canadian Securities Exchange
Fiscal Year	August - July
Reporting Currency	CAD
SIC Code	2836

Key Executives

Name	Position
Ian Campbell	Chief Executive Officer
Omar Gonzalez	Chief Financial Officer